{{Rsnum
|rsid=11199874
|Chromosome=10
|position=123032519
|Orientation=plus
|GMAF=0.214
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 37.2 | 56.6
| HCB | 7.3 | 32.1 | 60.6
| JPT | 5.3 | 24.8 | 69.9
| YRI | 0.7 | 17.0 | 82.3
| ASW | 1.8 | 17.5 | 80.7
| CHB | 7.3 | 32.1 | 60.6
| CHD | 10.1 | 36.7 | 53.2
| GIH | 2.0 | 21.8 | 76.2
| LWK | 0.9 | 12.7 | 86.4
| MEX | 5.2 | 43.1 | 51.7
| MKK | 1.9 | 17.3 | 80.8
| TSI | 7.8 | 40.2 | 52.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22130093
|Trait=None
|Title=New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
|RiskAllele=
|Pval=3E-10
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=22523086
|Title=Gene variants in the angiogenesis pathway and prostate cancer.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}